Your session is about to expire
← Back to Search
Investigator-designed lung transplant education resource (Research Intervention) for Cystic Fibrosis
N/A
Waitlist Available
Led By Kathleen Ramos, MD, MS
Research Sponsored by University of Washington
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up measured at baseline, 2-week and 4-week study visits
Awards & highlights
Study Summary
This trial is testing whether a research website helps prepare CF patients for discussions about lung transplant. It will span 4 weeks and involve 3 Zoom interviews and survey assessments.
Eligible Conditions
- Cystic Fibrosis
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ measured at baseline, 2-week and 4-week study visits
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~measured at baseline, 2-week and 4-week study visits
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Feasibility of Participants Completing 2-week Study Visit
Preparedness for Shared Decision Making (PrepDM) Scale
Secondary outcome measures
Confidence-weighted True False Knowledge About Lung Transplant (14-question Investigator-designed Survey)
Decisional Conflict Scale
Generalized Anxiety Disorder 7-item (GAD-7) Scale
+2 moreOther outcome measures
4-week Assessment for Confidence-weighted True False Knowledge About Lung Transplant (14-question Investigator-designed Survey)
4-week Assessment for Decisional Conflict Scale
4-week Assessment for Likert-scale Rating of Preparedness to Discuss Lung Transplant
+2 moreTrial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: InterventionExperimental Treatment1 Intervention
Access to an investigator-designed web-based educational resource with information about lung transplant for two weeks.
Group II: ControlActive Control1 Intervention
Access to a publicly available web-based educational resource with information about transplant for two weeks.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Investigator-designed lung transplant education resource (Research Intervention)
2021
N/A
~60
Find a Location
Who is running the clinical trial?
University of WashingtonLead Sponsor
1,741 Previous Clinical Trials
1,847,714 Total Patients Enrolled
24 Trials studying Cystic Fibrosis
45,815 Patients Enrolled for Cystic Fibrosis
Cystic Fibrosis FoundationOTHER
189 Previous Clinical Trials
37,158 Total Patients Enrolled
182 Trials studying Cystic Fibrosis
34,221 Patients Enrolled for Cystic Fibrosis
National Heart, Lung, and Blood Institute (NHLBI)NIH
3,837 Previous Clinical Trials
47,851,542 Total Patients Enrolled
37 Trials studying Cystic Fibrosis
12,650 Patients Enrolled for Cystic Fibrosis
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger